SCHEMBL13817751

SCHEMBL13817751

COC(=O)Cc1cnc(Cc2ccc(N(C)C(=O)c3ccc(Cl)c(Cl)c3)cc2)n2ccnc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 2/20 0.44
SMN1; SMN2 Q16637 5/20 0.41
MCHR1 Q99705 1/20 0.41
LMNA P02545 2/20 0.37
GPBAR1 Q8TDU6 1/20 0.33
MAPT P10636 3/20 0.33
PLA2G1B P04054 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
ATG4B Q9Y4P1 1/20 0.33
ALK Q9UM73 2/20 0.32
HPGD P15428 2/20 0.31
NPC1 O15118 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HTT P42858 1/20 0.31
RAB9A P51151 1/20 0.31
MDM2 Q00987 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13236240 0.86 PTGDR2 (0.47) PTGDR2SMN1; SMN2MAPTHPGDNPC1
SCHEMBL13236218 0.77 ALDH1A1 (0.37) NPC1ALDH1A1RAB9AKMT2A
SCHEMBL2939746 0.77 KDM4E (0.56) PTGDR2MEN1KMT2A
SCHEMBL13264602 0.75 EGFR (0.34) NPC1ALDH1A1RAB9A
SCHEMBL13236238 0.74 MAPT (0.39) PTGDR2LMNAMAPTCYP2C19ALDH1A1
SCHEMBL13236205 0.63 NPSR1 (0.37) SMN1; SMN2ALKHPGDNPC1ALDH1A1
SCHEMBL12415747 0.63 TLR7 (0.34) ALKKMT2A
SCHEMBL13264544 0.62 L3MBTL1 (0.32) ALKNPC1ALDH1A1RAB9AL3MBTL1
SCHEMBL13236209 0.62 PTGDR2 (0.47) PTGDR2SMN1; SMN2MCHR1LMNAMAPT
SCHEMBL2950642 0.62 PTGDR2 (0.44) PTGDR2CYP1A2CYP2C19ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1718649-B1 IMIDAZO 1,2-C PYRIMIDINYLACETIC ACID DERIVATIVES ACTIMIS PHARMACEUTICALS INC (US) 2009-06-10 EP disclosed